{{Rsnum
|rsid=187115
|Gene=CD44
|Chromosome=11
|position=35154612
|Orientation=minus
|GMAF=0.3448
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CD44
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 45.1 | 40.7 | 14.2
| HCB | 56.9 | 37.2 | 5.8
| JPT | 71.7 | 25.7 | 2.7
| YRI | 23.1 | 52.4 | 24.5
| ASW | 24.6 | 54.4 | 21.1
| CHB | 56.9 | 37.2 | 5.8
| CHD | 63.3 | 33.0 | 3.7
| GIH | 59.4 | 28.7 | 11.9
| LWK | 24.5 | 54.5 | 20.9
| MEX | 39.7 | 50.0 | 10.3
| MKK | 37.8 | 45.5 | 16.7
| TSI | 44.1 | 46.1 | 9.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=19996285
|Title=Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3tau and CD44 that affect sarcoma incidence and survival
}}

{{PMID Auto
|PMID=24971320
|Title=CD44 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}